Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions
Since December 2019, the SARS-CoV-2 (COVID-19) pandemic has transfixed the medical world. COVID-19 symptoms vary from mild to severe and underlying chronic conditions such as pulmonary/cardiovascular disease and diabetes induce excessive inflammatory responses to COVID-19 and these underlying chroni...
Main Authors: | Yujiro Matsuishi, Bryan J. Mathis, Nobutake Shimojo, Jesmin Subrina, Nobuko Okubo, Yoshiaki Inoue |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/3/279 |
Similar Items
-
ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01) -
Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
by: Sandeep Bansal, et al.
Published: (2020-05-01) -
COVID-19: when the world falls to its knees because of a virus
by: Yoana Mladenova, et al.
Published: (2020-07-01) -
Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01) -
Endothelial dysfunction and dynamics of cytokine and C-reactive protein levels in chronic heart failure patients
by: A. P. Rebrov, et al.
Published: (2005-04-01)